These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1717120

  • 1. Forskolin and phosphodiesterase inhibitors release adenosine but inhibit morphine-evoked release of adenosine from spinal cord synaptosomes.
    Nicholson D, White TD, Sawynok J.
    Can J Physiol Pharmacol; 1991 Jun; 69(6):877-85. PubMed ID: 1717120
    [Abstract] [Full Text] [Related]

  • 2. Effects of forskolin and phosphodiesterase inhibitors on spinal antinociception by morphine.
    Nicholson D, Reid A, Sawynok J.
    Pharmacol Biochem Behav; 1991 Apr; 38(4):753-8. PubMed ID: 1714608
    [Abstract] [Full Text] [Related]

  • 3. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase.
    Wright CD, Kuipers PJ, Kobylarz-Singer D, Devall LJ, Klinkefus BA, Weishaar RE.
    Biochem Pharmacol; 1990 Aug 15; 40(4):699-707. PubMed ID: 1696820
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
    Souness JE, Hassall GA, Parrott DP.
    Biochem Pharmacol; 1992 Sep 01; 44(5):857-66. PubMed ID: 1326964
    [Abstract] [Full Text] [Related]

  • 5. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
    Ransjö M, Fredholm BB, Lerner UH.
    Bone Miner; 1988 Jan 01; 3(3):225-34. PubMed ID: 2462948
    [Abstract] [Full Text] [Related]

  • 6. Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein.
    Wright IK, Amirchetty-Rao S, Kendall DA.
    Br J Pharmacol; 1994 Aug 01; 112(4):1146-50. PubMed ID: 7524992
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro.
    Lerner U, Ransjö M, Fredholm BB.
    Biochem Pharmacol; 1986 Dec 01; 35(23):4177-89. PubMed ID: 2431692
    [Abstract] [Full Text] [Related]

  • 8. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y, Endoh M.
    J Cardiovasc Pharmacol; 1992 Dec 01; 20(5):715-22. PubMed ID: 1280732
    [Abstract] [Full Text] [Related]

  • 9. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R, Pyne NJ, Furman BL.
    Br J Pharmacol; 1995 Aug 01; 115(8):1486-92. PubMed ID: 8564209
    [Abstract] [Full Text] [Related]

  • 10. Role of adenylate cyclase in presynaptic alpha 2-adrenoceptor- and mu-opioid receptor-mediated inhibition of [3H]noradrenaline release from rat brain cortex slices.
    Schoffelmeer AN, Wierenga EA, Mulder AH.
    J Neurochem; 1986 Jun 01; 46(6):1711-7. PubMed ID: 2422322
    [Abstract] [Full Text] [Related]

  • 11. Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitors.
    Wachtel H.
    J Neural Transm; 1983 Jun 01; 56(2-3):139-52. PubMed ID: 6190991
    [Abstract] [Full Text] [Related]

  • 12. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction.
    Muller B, Lugnier C, Stoclet JC.
    J Cardiovasc Pharmacol; 1990 Nov 01; 16(5):796-803. PubMed ID: 1703603
    [Abstract] [Full Text] [Related]

  • 13. Existence of rolipram-sensitive phosphodiesterase in rat megakaryocyte.
    Akaike N, Uneyama H, Kawa K, Yamashita Y.
    Br J Pharmacol; 1993 Aug 01; 109(4):1020-3. PubMed ID: 7691362
    [Abstract] [Full Text] [Related]

  • 14. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism.
    Zhu WH, Majluf-Cruz A, Omburo GA.
    Life Sci; 1998 Aug 01; 63(4):265-74. PubMed ID: 9698035
    [Abstract] [Full Text] [Related]

  • 15. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
    Weston MC, Anderson N, Peachell PT.
    Br J Pharmacol; 1997 May 01; 121(2):287-95. PubMed ID: 9154339
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of phosphodiesterase inhibitors on accumulation of cyclic AMP in isolated ventricular cardiomyocytes.
    Kelso EJ, McDermott BJ, Silke B.
    Biochem Pharmacol; 1995 Feb 14; 49(4):441-52. PubMed ID: 7872950
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effect of isobutylmethylxanthine and phosphodiesterase-selective inhibitors on cAMP levels in SH-SY5Y neuroblastoma cells.
    Morgan AJ, Murray KJ, Challiss RA.
    Biochem Pharmacol; 1993 Jun 22; 45(12):2373-80. PubMed ID: 7687130
    [Abstract] [Full Text] [Related]

  • 18. The stimulatory action of phosphodiesterase inhibitors on the flexor reflex of the hind limb in the spinal rat.
    Przegaliński E, Rawłów A.
    J Neural Transm; 1982 Jun 22; 55(1):9-17. PubMed ID: 6182270
    [Abstract] [Full Text] [Related]

  • 19. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells.
    Shimizu E, Kobayashi Y, Oki Y, Kawasaki T, Yoshimi T, Nakamura H.
    Life Sci; 1999 Jun 22; 64(23):2081-8. PubMed ID: 10372650
    [Abstract] [Full Text] [Related]

  • 20. Modulation of carbachol-induced inositol phosphate formation in bovine tracheal smooth muscle by cyclic AMP phosphodiesterase inhibitors.
    Hall IP, Donaldson J, Hill SJ.
    Biochem Pharmacol; 1990 Apr 15; 39(8):1357-63. PubMed ID: 1690998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.